Autopsy report · NCT02955121

IU Health Krannert Personalized Medicine Study

“Slower than anticipated recruitment”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 month before it started.
• Ran for about 3 years 2 months before it stopped.
• 107 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Indiana University

Sponsor type

University, hospital or other

Conditions

Coronary Artery Disease

Interventions

Prescriber Access to Genetic Information

Participants

107

Sites

1

Countries

United States

Trials that died the same way

• Serum-derived Bovine Immunoglobulin Effect on Mucositis
  “Recruitment slower than anticipated” (98% match in meaning)
• Pharmacokinetics of Ceftolozane/Tazobactam in Patients With Burns
  “Much slower recruitment than anticipated” (97% match in meaning)
• Pilot Study of Treatment for Subclinical AMR (Antibody-mediated Rejection) in Kidney Transplant Recipients
  “Slower than expected recruitment rate” (92% match in meaning)
• Post-Discharge Pharmacist-led Rapid Medication Optimization for Heart Failure (Post-Discharge PHARM-HF)
  “Slow recruitment” (92% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.